Optical Coherence Tomography – A New Monitoring Tool for Multiple Sclerosis?
isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group, Expert Opin Pharmacother, 2010;11:1225–30.
14. Tintore M, New options for early treatment of multiple sclerosis, J Neurol Sci, 2009;277(Suppl. 1):S9–S11.
15. Gilmore C, Cottrell D, Scolding N, et al., A window of opportunity for no treatment in early multiple sclerosis?, Mult Scler, 2010;16:756–9.
16. Burton EV, Greenberg BM, Frohman EM, Optic neuritis: A mechanistic view, Pathophysiology, 2010 May 14 (Epub ahead of print).
17. Oreja-Guevara C, Noval S, Manzano B, et al., Optic neuritis, multiple sclerosis-related or not: structural and functional study, Neurologia, 2010;25:78–82.
18. Polman CH, Reingold SC, Edan G, et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, Ann Neurol, 2005;58:840–46.
19. Beck RW, Trobe JD, Moke PS, et al., High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial, Arch Ophthalmol, 2003;121:944–9.
20. Meier DS, Weiner HL, Khoury SJ, et al., Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy, J Neuroimaging, 2004;14:46S–53S.
21. Evangelou N, Konz D, Esiri MM, et al., Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis, Brain, 2001;124:1813–20.
22. Balcer LJ, Clinical practice. Optic neuritis, N Engl J Med, 2006;354:1273–80.
23. Shams PN, Plant GT, Optic neuritis: a review, Int MS J, 2009;16:82–9.
24. Beck RW, Cleary PA, Anderson MM, Jr., et al., A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group, N Engl J Med, 1992;326:581–8.
25. Optic Neuritis Study Group, The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group, Arch Ophthalmol, 1991;109: 1673–8.
26. Morrissey SP, Miller DH, Kendall BE, et al., The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study, Brain, 1993;116(Pt 1):135–46.
27. Tintore M, Rovira A, Rio J, et al., Do oligoclonal bands add
information to MRI in first attacks of multiple sclerosis?, Neurology, 2008;70:1079–83.
28. Newman NJ, Multiple sclerosis and related demyelinating diseases. In: Miller NR, Newman NJ (eds.), Walsh and Hoyt’s Clinical Neuro-Ophthalmology, Baltimore: Williams and Wilkins, 1998;5539–76.
29. Baier ML, Cutter GR, Rudick RA, et al., Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis, Neurology, 2005;64:992–5.
30. Mowry EM, Loguidice MJ, Daniels AB, et al., Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity, J Neurol Neurosurg Psychiatry, 2009;80:767–72.
31. The Optic Neuritis Study Group, Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group, Arch Ophthalmol, 1997;115:1545–52.
32. Huang D, Swanson EA, Lin CP, et al., Optical coherence tomography, Science, 1991;254:1178–81.
33. van Velthoven ME, Faber DJ, Verbraak FD, et al., Recent developments in optical coherence tomography for imaging the retina, Prog Retin Eye Res, 2007;26:57–77.
34. Frohman EM, Fujimoto JG, Frohman TC, et al., Optical coherence tomography: a window into the mechanisms of multiple sclerosis, Nat Clin Pract Neurol, 2008;4:664–75.
35. Monteiro ML, Leal BC, Rosa AA, et al., Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve, Br J Ophthalmol, 2004;88:896–9.
36. Sergott RC, Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis, Curr Opin Ophthalmol, 2005;16:346–50.
37. Sakata LM, Deleon-Ortega J, Sakata V, et al., Optical coherence tomography of the retina and optic nerve – a review, Clin Experiment Ophthalmol, 2009;37:90–99.
38. Hickman SJ, Optic nerve imaging in multiple sclerosis, J Neuroimaging, 2007;17(Suppl. 1):42S–5S.
39. Hickman SJ, Brierley CM, Brex PA, et al., Continuing optic nerve atrophy following optic neuritis: a serial MRI study, Mult Scler, 2002;8:339–42.
40. Trip SA, Schlottmann PG, Jones SJ, et al., Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy, Neuroimage, 2006;31:286–93.
41. Feinsod M, Hoyt WF, Subclinical optic neuropathy in multiple sclerosis. How early VER components reflect axon loss and conduction defects in optic pathways,
J Neurol Neurosurg Psychiatry, 1975;38:1109–14.
42. Filippi M, Bozzali M, Rovaris M, et al., Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis, Brain, 2003;126:433–7.
43. Trip SA, Schlottmann PG, Jones SJ, et al., Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis, Ann Neurol, 2005;58:383–91.
44. Fisher JB, Jacobs DA, Markowitz CE, et al., Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis, Ophthalmology, 2006;113:324–32.
45. Toledo J, Sepulcre J, Salinas-Alaman A, et al., Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis, Mult Scler, 2008;14:906–12.
46. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, et al., Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS, Neurology, 2007;68:1488–94.
47. Costello F, Hodge W, Pan YI, et al., Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes, J Neurol Sci, 2009;281:74–9.
48. Outteryck O, Zephir H, Defoort S, et al., Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss, Arch Neurol, 2009;66:1373–7.
49. Gordon-Lipkin E, Chodkowski B, Reich DS, et al., Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis, Neurology, 2007;69:1603–9.
50. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al., Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis, J Neurol Sci, 2008;268:12–17.
51. Cettomai D, Pulicken M, Gordon-Lipkin E, et al., Reproducibility of optical coherence tomography in multiple sclerosis, Arch Neurol, 2008;65:1218–22.
52. NCT00910598, Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) (OCTIMS), 2009. Available at:
clinicaltrials.gov/ct2/show/NCT00910598? term=OCTIMS&rank=1 (accessed October 2009).
53. NCT01071512, Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis, 2010. Available at:
clinicaltrials.gov/ct2/show/NCT01071512? term=optical+coherence+tomography+AND+multiple+ sclerosis&rank=3 (accessed February 2010).
54. Henderson AP, Trip SA, Schlottmann PG, et al., A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis, J Neurol, 2010;257:1083–91.
EUROPEAN NEUROLOGICAL REVIEW
77
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116